Featuring: publicly traded & venture capital companies on the U.S. (NYSE, NASDAQ, AMEX & OTC: BB) and Canadian (TSX & TSX-V) stock exchanges, Investment & Money Management Ideas. |
|
|
Press Release - Provectus Pharmaceuticals, Inc. (PVCT-OCT: BB) |
|
|
We have solved the essential problem that other scientists and companies have not been able to solve; that is to make a cancer specific drug. We have found out how to make it simply, pragmatically and inexpensively; namely, to build it and make a very safe molecule. - Dr. H. Craig Dees, Ph.D. (PVCT) (Interview published April 12, 2007) |
The Most Powerful Name In Corporate News and Information. |
|
CURRENT ISSUE | COVER ARCHIVES | INDEX | CONTACT | FINANCIALS | MARKETING SERVICES | HOME PAGE |
|
Provectus News Maxim Group
Issues Company Update on Provectus Maxim Group has issued an Equity Research Company Updatet reiterating a buy rating for Provectus based on positive PV-10 for melanoma Phase II data provided by Provectus's 2010 ASCO abstract. A copy of the report in PDF format is attached. If you are unable to read the attached copy, or would like request a copy, please contact Marlon Nurse of Porter, LeVay, & Rose at +1 (212)-564-4700, or e-mail Peter Culpepper, CFO/COO at culpepper@pvct.com. Provectus
Presenting at SCIA Summer Conference The Southern California Investment Association has announced that Provectus will be presenting at the SCIA Summer Conference. The SCIA Summer Conference will be held Saturday June 5, 2010 at the Hilton Hotel/Orange County Airport in Irvine, CA. The article is available at http://www.marketwire.com/press-release/SCIA-Announces-Additional-Companies-TSX-NNN-1264582.htm.
|
|
